AVROBIO Inc
NASDAQ:TECX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AVROBIO Inc
NASDAQ:TECX
|
US |
|
Aegon NV
F:AEND
|
NL |
|
A
|
Air Products and Chemicals Inc
BMV:APD
|
US |
|
L
|
London Stock Exchange Group PLC
XMUN:LS4C
|
UK |
|
I
|
Ingersoll Rand Inc
F:5GD
|
US |
|
C
|
CME Group Inc
XMUN:MX4A
|
US |
|
SMCP SA
F:SFC
|
FR |
|
M
|
MTR Corp Ltd
SWB:MRI
|
HK |
|
B
|
Box Inc
F:3BX
|
US |
|
F
|
Fuji Media Holdings Inc
F:FTN
|
JP |
|
P
|
Panasonic Holdings Corp
F:MAT1
|
JP |
|
Rexford Industrial Realty Inc
F:3I0
|
US |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
Prudential PLC
LSE:PRU
|
UK |
|
G
|
GFPT PCL
SET:GFPT
|
TH |
|
Cedar Woods Properties Ltd
ASX:CWP
|
AU |
|
R
|
Rewalk Robotics Ltd
F:2RW
|
IL |
|
M
|
Mitsubishi UFJ Financial Group Inc
XMUN:MFZ
|
JP |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
B
|
BCPG PCL
SET:BCPG
|
TH |
Bankruptcy Probability
AVROBIO Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AVROBIO Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
AVROBIO Inc
NASDAQ:TECX
|
670.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
451.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AVROBIO Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AVROBIO Inc has total debt of 17k USD. This includes both short-term (0 USD) and long-term (17k USD) debt.
You can find a full breakdown on its Balance Sheet.
